Stock screener

IMDX

Conviction 71HealthcareScan · Thu, Jun 25, 2026
Bullish belt hold
IMDX$5.58+3.72%
ResistanceSupportVol 14Insider buy
63 bars
6
6
6
6
6
6
Vol MA14 309.8K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Insight Molecular Diagnostics Inc.IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESwww.imdxinc.com
Price5.58
Change+3.72%
Gap+1.02%
Rel volume1.45×
Avg volume285.63K
Avg $ vol1.63M
SMA 205.73
SMA 505.19
SMA 2005.28
Price vs 50+7.50%
Price vs 200+5.70%
MA stackmixed
50/200 cross
Supertrendup · 4.50
RSI (14)51
MACD hist-0.08
MACD cross
Stoch %K / %D52 / 41
ADX (14)24
+DI / −DI15 / 19
RSI divergenceBearish
MACD divergenceBearish
ATR %+10.70%
ADR %10.67%
52w high8.48
52w low2.40
From 52w high-34.20%
Above 52w low+132.50%
New 52w highNo
SqueezeOff
Bollinger width27.19%
%B0.41
Donchian pos44.78%
Donchian high6.85
Donchian low4.55
AVWAP (52w high)4.91
vs AVWAP high+13.64%
AVWAP (52w low)4.90
vs AVWAP low+13.78%
OBV trendUp
Chaikin MF (20)0.05
Today vs 20d1.45×
Avg vol (14d)309.8K
Avg vol (20d)285.63K
Avg $ vol (20d)1.63M
Market cap180.18M
RS 3m (vs SPY)+22.24%
RS 6m (vs SPY)-8.29%
RS line new highNo
Trend template6/8
Technical rank55.4
1 week+4.89%
1 month-13.35%
3 months+34.78%
6 months+0.36%
1 year+61.74%
YTD-22.07%
P/E-3.59
P/B-16.85
P/S44.43
P/FCF-7.10
EPS-1.65
Div yield
ROE469.76%
ROA-124.23%
Debt/Eq-0.17
Current2.54
EV/EBITDA-3.14
Gross margin56.67%
Net margin
Rev growth115.58%
EPS growth17.21%
Price target
Target upside
Analyst rating
Institutional
Ent. value153.85M
Revenue32K
Net income-4.29M
Gross profit15K
Free cash flow-25.37M
IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
ExchangeNasdaq
Shares out32.29M
Employees58
ListedWed, Dec 30, 2015
Free float25.48M
Float %78.9%
Short interest1.28M
Days to cover4.0d
Short volume37.6%
Squeeze score37 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeB
Conviction71 / 100
Pattern quality
Tech rank55.4 / 100
Group rank50 / 100
Status lane
Setup direction
Pattern family
Resistance
Support
Days since event
Candle confirmBullish belt hold
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IMDX

All disclosures →
No recent disclosed trades by Congress in IMDX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IMDX · 10 buys

InsiderSideShares
BROADWOOD PARTNERS, L.P.
10% owner · Common Stock, no par value · 2026-04-27
Buy0
BROADWOOD PARTNERS, L.P.
10% owner · Common Stock, no par value · 2026-04-27
Buy250.92K
BROADWOOD CAPITAL INC
10% owner · Common Stock, no par value · 2026-04-27
Buy0
BROADWOOD CAPITAL INC
10% owner · Common Stock, no par value · 2026-04-27
Buy250.92K
Bradsher Neal C
10% owner · Common Stock, no par value · 2026-04-27
Buy250.92K
Bradsher Neal C
10% owner · Common Stock, no par value · 2026-04-27
Buy0
BROADWOOD CAPITAL INC
10% owner · Common Stock, no par value · 2026-04-24
Buy38.88K
BROADWOOD PARTNERS, L.P.
10% owner · Common Stock, no par value · 2026-04-24
Buy38.88K
Bradsher Neal C
10% owner · Common Stock, no par value · 2026-04-24
Buy38.88K
Bradsher Neal C
10% owner · Common Stock, no par value · 2026-04-24
Buy0

SEC filings

EDGAR filings in IMDX · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.